Literature DB >> 19651675

Hypercholesterolemia impairs exercise capacity in mice.

Andrew J Maxwell1, Josef Niebauer, Patrick S Lin, Philip S Tsao, Daniel Bernstein, John P Cooke.   

Abstract

We previously reported an attenuation of both exercise hyperemia and measures of aerobic capacity in hypercholesterolemic mice. In this study, we expanded upon the previous findings by examining the temporal and quantitative relationship of hypercholesterolemia to aerobic and anaerobic capacity and by exploring several potential mechanisms of dysfunction. Eight-week-old wild type (n = 123) and apoE knockout (n = 79) C57BL/6J mice were divided into groups with distinct cholesterol levels by feeding with regular or high-fat diets. At various ages, the mice underwent treadmill ergospirometry. To explore mechanisms, aortic ring vasodilator function and nitrate (NO(x)) activity, urinary excretion of NO(x), running muscle microvascular density and citrate synthase activity, as well as myocardial mass and histologic evidence of ischemia were measured. At 8 weeks of age, all mice had similar measures of exercise capacity. All indices of aerobic exercise capacity progressively declined at 12 and 20 weeks of age in the hypercholesterolemic mice as cholesterol levels increased while indices of anaerobic capacity remained unaffected. Across the four cholesterol groups, the degree of aerobic dysfunction was related to serum cholesterol levels; a relationship that was maintained after correcting for confounding factors. Associated with the deterioration in exercise capacity was a decline in measures of nitric oxide-mediated vascular function while there was no evidence of aberrations in functional or oxidative capacities or in other components of transport capacity. In conclusion, aerobic exercise dysfunction is observed in murine models of genetic and diet-induced hypercholesterolemia and is associated with a reduction in vascular nitric oxide production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651675      PMCID: PMC3140166          DOI: 10.1177/1358863X08100040

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  44 in total

Review 1.  Endothelium-dependent effects of statins.

Authors:  Sebastian Wolfrum; Kristin S Jensen; James K Liao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-27       Impact factor: 8.311

2.  Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine.

Authors:  J J Jang; H K Ho; H H Kwan; L F Fajardo; J P Cooke
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

4.  Determination of serum creatinine by a direct colorimetric method.

Authors:  D Heinegård; G Tiderström
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

5.  Effect of maximal oxygen uptake and different forms of physical training on serum lipoproteins.

Authors:  A Schnabel; W Kindermann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982

6.  The role of blood flow in limiting maximal metabolic rate in muscle.

Authors:  J K Barclay; W N Stainsby
Journal:  Med Sci Sports       Date:  1975

7.  Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

Authors:  A Ito; P S Tsao; S Adimoolam; M Kimoto; T Ogawa; J P Cooke
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

8.  Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease.

Authors:  Sergio Mondillo; Piercarlo Ballo; Riccardo Barbati; Francesco Guerrini; Tiziana Ammaturo; Eustachio Agricola; Monica Pastore; Francesco Borrello; Mirko Belcastro; Andrea Picchi; Renato Nami
Journal:  Am J Med       Date:  2003-04-01       Impact factor: 4.965

9.  Physical performance and serum cholesterol fractions in healthy young men.

Authors:  A Berg; J Keul; G Ringwald; B Deus; K Wybitul
Journal:  Clin Chim Acta       Date:  1980-10-09       Impact factor: 3.786

10.  Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.

Authors:  Emile R Mohler; William R Hiatt; Mark A Creager
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more
  9 in total

Review 1.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

2.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

3.  Reduced contribution of endothelin to the regulation of systemic and pulmonary vascular tone in severe familial hypercholesterolaemia.

Authors:  Shawn B Bender; Vincent J de Beer; Darla L Tharp; Elza D van Deel; Douglas K Bowles; Dirk J Duncker; M Harold Laughlin; Daphne Merkus
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

4.  Differential impact of severe familial hypercholesterolemia on regional skeletal muscle and organ blood flows during exercise: Effects of PDE5 inhibition.

Authors:  Christian G Aragonez; Vincent J de Beer; Darla L Tharp; Douglas K Bowles; M Harold Laughlin; Daphne Merkus; Dirk J Duncker; Shawn B Bender
Journal:  Microcirculation       Date:  2019-03-26       Impact factor: 2.628

5.  Exercise capacity and cardiac hemodynamic response in female ApoE/LDLR(-/-) mice: a paradox of preserved V'O2max and exercise capacity despite coronary atherosclerosis.

Authors:  M Wojewoda; U Tyrankiewicz; P Gwozdz; T Skorka; M Jablonska; A Orzylowska; K Jasinski; A Jasztal; K Przyborowski; R B Kostogrys; J A Zoladz; S Chlopicki
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

Review 6.  Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart.

Authors:  Csaba Csonka; Márta Sárközy; Márton Pipicz; László Dux; Tamás Csont
Journal:  Oxid Med Cell Longev       Date:  2015-12-14       Impact factor: 6.543

Review 7.  Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.

Authors:  Peggy Sfyri; Antonios Matsakas
Journal:  J Biomed Sci       Date:  2017-07-08       Impact factor: 8.410

8.  Development of a two-stage limb ischemia model to better simulate human peripheral artery disease.

Authors:  Smriti M Krishna; Safraz Mohamed Omer; Jiaze Li; Susan K Morton; Roby J Jose; Jonathan Golledge
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

9.  The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy.

Authors:  Hae R Chung; Mayand Vakil; Michael Munroe; Alay Parikh; Benjamin M Meador; Pei T Wu; Jin H Jeong; Jeffrey A Woods; Kenneth R Wilund; Marni D Boppart
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.